In this issue:
Rapid vs slow antipsychotic initiation in schizophrenia
Omega-3 in the treatment of violent schizophrenia patients
Attenuated psychotic symptoms in offspring of schizophrenia patients
Feasibility of remotely delivering cognitive training to people with schizophrenia
Omega-3 fatty acids and cognitive impairment in schizophrenia
Adjunctive celecoxib for schizophrenia
Predictors of treatment response and drop out in early-onset schizophrenia
Social predictors of clinical recovery in first-episode psychosis
Widespread volumetric reductions in schizophrenia displaying compromised cognitive abilities
Blood-based protein changes in childhood are associated with increased risk for later psychotic disorder
Please login below to download this issue (PDF)